Conventional and Bayesian workflows for clinical prediction modelling of severe Covid-19 outcomes based on clinical biomarker test results: LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
Brian Sullivan, Edward Barker, Philip Williams, Louis MacGregor, View ORCID ProfileRanjeet Bhamber, View ORCID ProfileMatt Thomas, Stefan Gurney, Catherine Hyams, Alastair Whiteway, Jennifer A Cooper, Chris McWilliams, Katy Turner, View ORCID ProfileAndrew W. Dowsey, Mahableshwar Albur
doi: https://doi.org/10.1101/2022.09.16.22279985
Brian Sullivan
aUniversity Of Bristol
Edward Barker
aUniversity Of Bristol
Philip Williams
cUniversity Hospitals Bristol and Weston NHS Trust
Louis MacGregor
aUniversity Of Bristol
Ranjeet Bhamber
aUniversity Of Bristol
Matt Thomas
bSouthmead Hospital, North Bristol NHS Trust
Stefan Gurney
cUniversity Hospitals Bristol and Weston NHS Trust
Catherine Hyams
aUniversity Of Bristol
bSouthmead Hospital, North Bristol NHS Trust
Alastair Whiteway
bSouthmead Hospital, North Bristol NHS Trust
Jennifer A Cooper
aUniversity Of Bristol
Chris McWilliams
aUniversity Of Bristol
Katy Turner
aUniversity Of Bristol
Andrew W. Dowsey
aUniversity Of Bristol
Mahableshwar Albur
bSouthmead Hospital, North Bristol NHS Trust
Data Availability
Due to NHS data governance, all data produced in the present study are unavailable directly through the authors, but reasonable requests for data to Southwest England NHS can be arranged via the authors.
Posted April 26, 2023.
Conventional and Bayesian workflows for clinical prediction modelling of severe Covid-19 outcomes based on clinical biomarker test results: LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
Brian Sullivan, Edward Barker, Philip Williams, Louis MacGregor, Ranjeet Bhamber, Matt Thomas, Stefan Gurney, Catherine Hyams, Alastair Whiteway, Jennifer A Cooper, Chris McWilliams, Katy Turner, Andrew W. Dowsey, Mahableshwar Albur
medRxiv 2022.09.16.22279985; doi: https://doi.org/10.1101/2022.09.16.22279985
Conventional and Bayesian workflows for clinical prediction modelling of severe Covid-19 outcomes based on clinical biomarker test results: LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
Brian Sullivan, Edward Barker, Philip Williams, Louis MacGregor, Ranjeet Bhamber, Matt Thomas, Stefan Gurney, Catherine Hyams, Alastair Whiteway, Jennifer A Cooper, Chris McWilliams, Katy Turner, Andrew W. Dowsey, Mahableshwar Albur
medRxiv 2022.09.16.22279985; doi: https://doi.org/10.1101/2022.09.16.22279985
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)